CAPR · As filed with the SEC
Capricor Therapeutics balance sheet, by fiscal year
The statement as Capricor Therapeutics presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED BALANCE SHEETS · USD
| USD | FY2025 Dec 31, 2025 | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 | FY2021 Dec 31, 2021 | FY2020 Dec 31, 2020 | FY2019 Dec 31, 2019 | FY2018 Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| CURRENT ASSETS | ||||||||
| Cash and cash equivalents | 287,847,312 | 11,286,996 | 14,694,857 | 9,603,242 | 34,885,274 | 32,665,874 | 3,899,328 | 4,259,266 |
| Marketable securities | — | 140,228,881 | 24,792,846 | 31,818,020 | — | — | 5,986,050 | 2,997,150 |
| Restricted cash | — | — | — | — | — | — | 0 | 285,831 |
| Marketable securities | 30,281,603 | — | — | — | — | — | — | — |
| Receivables | 59,167 | 10,368,489 | 10,371,993 | 547,580 | 391,750 | — | 87,968 | 204,868 |
| Prepaid expenses and other current assets | 4,751,674 | 1,500,901 | 995,776 | 919,892 | 1,159,937 | 1,011,209 | 571,382 | 724,184 |
| TOTAL CURRENT ASSETS | 322,939,756 | 163,385,267 | 50,855,472 | 42,888,734 | 36,436,961 | 33,677,083 | 10,544,728 | 8,471,299 |
| PROPERTY AND EQUIPMENT, net | 18,312,238 | 5,561,597 | 5,560,641 | 4,588,030 | 1,795,696 | 850,847 | 442,806 | 574,206 |
| OTHER ASSETS | ||||||||
| Intangible assets, net of accumulated amortization of $259,682 and $257,517, respectively | — | — | — | — | 0 | 2,165 | 6,495 | 49,772 |
| Lease right-of-use assets, net | 13,537,820 | 1,312,522 | 2,050,042 | 2,349,974 | 2,821,944 | — | — | — |
| Other assets | 1,159,480 | 221,700 | 268,172 | 268,172 | 275,722 | 88,701 | 119,608 | 151,788 |
| TOTAL ASSETS | 355,949,294 | 170,481,086 | 58,734,327 | 50,094,910 | 41,330,323 | 34,618,796 | 11,113,637 | 9,247,065 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| CURRENT LIABILITIES | ||||||||
| Accounts payable and accrued expenses | — | 8,191,377 | 6,222,762 | 4,834,683 | 3,116,371 | 2,724,593 | 875,677 | 1,148,853 |
| Accounts payable and accrued expenses, related party | — | — | — | — | 599,388 | — | 22,315 | 106,366 |
| Note payable, current | — | — | — | — | 0 | 246,689 | — | — |
| Accounts payable and accrued expenses, related party | — | — | — | 89,234 | — | — | — | — |
| Accounts payable and accrued expenses, related party | — | — | 27,479 | — | — | — | — | — |
| Accounts payable | 1,654,754 | — | — | — | — | — | — | — |
| Accrued expenses | 15,557,646 | — | — | — | — | — | — | — |
| Lease liabilities, current | 202,376 | 834,799 | 749,112 | 682,039 | 417,632 | — | — | — |
| CIRM liability, current | 6,421,984 | — | — | — | — | — | — | — |
| Deferred revenue, current | 12,000,000 | 12,000,000 | 24,270,465 | 17,980,599 | — | — | — | — |
| TOTAL CURRENT LIABILITIES | 35,836,760 | 21,026,176 | 31,269,818 | 23,586,555 | 4,133,391 | 2,971,282 | 897,992 | 1,255,219 |
| LONG-TERM LIABILITIES | ||||||||
| Note payable, net of current | — | — | — | — | 0 | 71,471 | — | — |
| CIRM liability | — | — | — | — | 3,376,259 | 3,376,259 | 3,376,259 | 3,376,259 |
| CIRM liability | — | — | 3,376,259 | 3,376,259 | — | — | — | — |
| CIRM liability, net of current | 0 | 3,376,259 | — | — | — | — | — | — |
| Lease liabilities, net of current | 14,320,389 | 616,315 | 1,486,783 | 1,878,070 | 2,452,707 | — | — | — |
| Deferred revenue, net of current | — | — | 0 | 9,467,932 | — | — | — | — |
| TOTAL LONG-TERM LIABILITIES | 14,320,389 | 3,992,574 | 4,863,042 | 14,722,261 | 5,828,966 | 3,447,730 | 3,376,259 | 3,376,259 |
| TOTAL LIABILITIES | 50,157,149 | 25,018,750 | 36,132,860 | 38,308,816 | 9,962,357 | 6,419,012 | 4,274,251 | 4,631,478 |
| STOCKHOLDERS' EQUITY | ||||||||
| Preferred stock, $0.001 par value, 5,000,000 shares authorized, none issued and outstanding | — | — | — | — | — | — | 0 | 0 |
| Common stock, $0.001 par value, 100,000,000 shares authorized, 57,370,909 and 45,582,288 shares issued and outstanding, respectively | 57,371 | 45,582 | 31,148 | 25,241 | 24,185 | 20,577 | 5,227 | 31,388 |
| Additional paid-in capital | 610,330,105 | 344,224,338 | 181,701,859 | 148,735,420 | 139,404,060 | 116,216,966 | 81,215,647 | 71,310,720 |
| Accumulated other comprehensive income | 283,154 | 1,026,955 | 235,813 | 105,244 | — | — | (757) | 12,393 |
| Accumulated deficit | (304,878,485) | (199,834,539) | (159,367,353) | (137,079,811) | (108,060,279) | (88,037,759) | (74,380,731) | (66,738,914) |
| TOTAL STOCKHOLDERS' EQUITY | 305,792,145 | 145,462,336 | 22,601,467 | 11,786,094 | 31,367,966 | 28,199,784 | 6,839,386 | 4,615,587 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | 355,949,294 | 170,481,086 | 58,734,327 | 50,094,910 | 41,330,323 | 34,618,796 | 11,113,637 | 9,247,065 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.
Data on this page was fetched . The filing on SEC.gov is the record.